Long-acting insulin analogue detemir compared with NPH insulin in type 1 diabetes. A systematic review and meta-analysis

2011 ◽  
Vol 121 (7-8) ◽  
pp. 237-246 ◽  
Author(s):  
Agnieszka Szypowska ◽  
Dominik Golicki ◽  
Lidia Groele ◽  
Ewa Pańkowska
Keyword(s):  
Systematic Review ◽  
Type 1 Diabetes ◽  
Insulin Analogue ◽  
Meta Analysis ◽  
Nph Insulin ◽  
Acting Insulin ◽  
Long Acting

scholarly journals Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials

PLoS ONE ◽  
2018 ◽  
Vol 13 (4) ◽  
pp. e0194801 ◽  
Author(s):  
Fernanda O. Laranjeira ◽  
Keitty R. C. de Andrade ◽  
Ana C. M. G. Figueiredo ◽  
Everton N. Silva ◽  
Mauricio G. Pereira
Keyword(s):  
Type 1 Diabetes ◽  
Randomized Controlled Trials ◽  
Meta Analysis ◽  
Insulin Analogues ◽  
Controlled Trials ◽  
Randomized Controlled ◽  
Acting Insulin ◽  
Overview Of Systematic Reviews ◽  
Long Acting

scholarly journals Insulin degludec: The new standard long acting insulin analogue for people with type 1 diabetes? [Letter to the Editor]

2016 ◽  
Vol 63 (4) ◽  
pp. 411-412 ◽  
Author(s):  
Agustín Ángel Merchante-Alfaro ◽  
Susana Pérez-Naranjo ◽  
Pablo Abellán-Galiana ◽  
Olalla Rubio-Puchol
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Analogue ◽  
Insulin Degludec ◽  
Acting Insulin ◽  
Letter To The Editor ◽  
Long Acting
Sign in / Sign up

Export Citation Format

Share Document